Evaluation of Anti-SARS-Cov-2 S-RBD IgG Antibodies after COVID-19 mRNA BNT162b2 Vaccine.
Diagnostics (Basel)
; 11(7)2021 Jun 22.
Article
in En
| MEDLINE
| ID: mdl-34206567
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Language:
En
Journal:
Diagnostics (Basel)
Year:
2021
Document type:
Article
Affiliation country:
Italy
Country of publication:
Switzerland